Friday, August 11, 2023: M&A

Danish drugmaker Novo Nordisk has agreed to buy Inversago Pharma, a Montreal-based developer of anti-obesity drugs, for upwards of $1.1 billion in cash. Novo isn’t content to rest on its weight loss laurels, despite the popularity of its Ozempic and Wegovy...

Thursday, August 10, 2023: Payers

Most Medicare Advantage (MA) beneficiaries are satisfied with their health plan, but many enrollees feel they are overbilled, have struggled to navigate the prior authorization process, or are confused by the features of their plan, a new survey from Retirement Living...

Thursday, August 10, 2023: Providers

Health care workers are increasingly being assaulted or shot on the job, making hospitals and clinics among the most dangerous workplaces in America. According to the Association of American Medical Colleges, hospitals are strengthening efforts to identify security...